ProCertus BioPharm secures $2.3M in financing
ProCertus BioPharm, an oncology-based pharmaceutical company, has closed on a $2.3 million stock financing led by Venture Investors. ProCertus develops therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, and will use the financing to begin clinical trials on cancer patients. ...